Home › Mutual Funds › Nippon India Mutual Fund › Nippon India Pharma Fund - Direct Plan - Growth Plan
Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund - Direct Plan - Growth Plan

Add To Compare

previously known as Reliance Pharma Dir Gr until

582.998 (0.868%)
NAV on October 11, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 8,769 cr
Turnover Ratio 16.09%
Expense Ratio 0.90%
Exit Load 1.00%if redeemed within
1 Months0.00%if redeemed after 1 Months
Returns
  • 1M: 1.02%
  • 1Y: 52.43%
  • 3M: 14.51%
  • 3Y: 20.48%
  • 6M: 22.73%
  • 5Y: 31.75%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since over 19 years) Kinjal Desai (Since over 6 years)
ISIN INF204K01I50
Fund Family Nippon India
P/E Ratio 41.77
P/B Ratio 7.17
Launch Date January 01, 2013
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha 1.36
Beta 0.91
R-Squared 95.84
Info Ratio 0.12
Tracking Err 3.37
Sortino 1.674
Sharpe 0.929
Std Dev 15.194
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Quant
Quant Healthcare Fund Direct Growth
17.755 66.39% 432 cr 0.69% -
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
41.910 63.90% 4,987 cr 1.06% -
Tata
Tata India Pharma & Healthcare Fund Direct Growth
36.039 58.51% 1,208 cr 0.72% -
Sbi
SBI Healthcare Opportunities Fund Direct Growth
479.545 53.91% 3,346 cr 0.89% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon India

Data Partner
Click here to visit AMC website and
read all scheme related documents Nippon India Fund